NCRP

Program Areas

Current Program

The Council’s current scientific program consists of a council committee (CC), seven program area committees (PACs), and an advisory panel.


Committee

Title

Chair

CC 2 Meeting the Needs of the Nation for Radiation Protection
Newhauser,W

WAYNE D. NEWHAUSER

Newhauser,W

is the Director of the Medical and Health Physics Program at Louisiana State University in Baton Rouge, holder of the Dr. Charles M. Smith Chair in Medical Physics, and Chief of Physics at the Mary Bird Perkins Cancer Center. He is a board certified and licensed medical physicist with specialization in advanced-technology radiotherapies. Dr. Newhauser is an expert in proton radiation therapy, dose reconstructions, and risk estimation and reduction. His current research projects seek to improve long-term outcomes of survivors of childhood and adult cancers. He and his multidisciplinary team of collaborators are known for their early use of Monte-Carlo methods and high-performance computing in proton therapy, including neutron shielding, treatment planning, and estimation of stray radiation exposures. He received the Innovation Excellence Award in 2012 in recognition of his laboratory's research involving in-silico clinical trials to compare advanced-technology radiotherapies.

Dr. Newhauser has published more than 85 peer-reviewed journal articles, leads federal research grants, and mentors graduate students and post-doctoral fellows. He has served in leadership roles in the American Association of Physicists in Medicine, the American Nuclear Society, and the Health Physics Society. He serves on the International Advisory Board of the journal Physics In Medicine and Biology and is a corresponding member of EURODOS. After receiving a BS in nuclear engineering and MS and PhD degrees medical physics from the University of Wisconsin, he worked at the German National Standards Laboratory, Harvard Medical School and Massachusetts General Hospital, and The University of Texas MD Anderson Cancer Center.

wayne d. newhauser
Williams J

JACQUELINE P. WILLIAMS

completed her undergraduate degrees at the University of Nottingham, followed by her post-doctoral training in radiation biology at St. Bartholomew's Hospital, University of London, United Kingdom. Shortly after completing her studies, she joined the faculty at the University of Rochester, New York, in the department of Radiation Oncology and, later, in the department of Environmental Medicine. Over her career, Dr. Williams has served as the President of the Radiation Research Society, the Research Chair on the Board of the American Society for Radiation Oncology, and Council Member to the International Association for Radiation Research, as well as associate editor on several radiation-related journals, including the International Journal of Radiation Biology.

Although now semi-retired, Dr. Williams has accrued nearly 40 y of experience in radiation biology and related fields and has been involved in a wide range of research areas, clinically-related oncologic studies and clinical trials, tumor blood flow studies, long-term carcinogenic studies, and pharmacological and toxicological projects. In particular, her research involved identifying mechanisms that underlie the initiation and progression of radiation-induced late normal tissue effects as a consequence of accidental exposures or the low doses associated with either space travel or mass terrorism events, with the goal of developing protection and/or mitigation strategies.

jacqueline p. williams
PAC 1 Woloschak-G

GAYLE E. WOLOSCHAK

is a Professor of Radiation Oncology and Radiology at Northwestern University Feinberg School of Medicine in Chicago and Associate Dean of the Graduate School. She and her group have been involved in studies of molecular consequences of radiation exposure, late tissue effects associated with radiation, and the use of radiation-inducible nanomaterials for cancer imaging and therapy. Dr. Woloschak also teaches radiation biology to radiation oncology and radiology residents, cardiology trainees, and graduate students and manages the Advanced Grant Writing Workshop for the Radiological Society of North America (RSNA). She earned her PhD in medical sciences from the University of Toledo (Ohio) and did post-doctoral studies in molecular biology at the Mayo Clinic. She has served on review panels for various federal agencies including the National Institutes of Health, the National Aeronautics and Space Administration, the U.S. Department of Energy, RSNA, the U.S. Army Medical Research and Materiel Command, and others. She is currently Editor-in-Chief for the International Journal of Radiation Biology, Section Editor for PLOS One, and serves on a variety of editorial boards. She is Chair of NCRP Program Area Committee 1, has served on organizational committees for several NCRP meetings, and has been involved in committees for several NCRP reports. She also served as President of the Radiation Research Society and is a member of the U.S. delegation to the United Nations Scientific Committee on the Effects of Atomic Radiation.

gayle e. woloschak
Bernstein

Jonine L. Bernstein

Bernstein

is an Attending Epidemiologist at the Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City. Her core research focus is on breast cancer and gliomas and on understanding cancer risk and progression in order to identify those at highest risk because of gene carrier status, environmental exposures, or a combination of both. Dr. Bernstein is the Principle Investigator of the National Cancer Institute (NCI)-funded international 24-center Women's Environmental Cancer Radiation and Epidemiologic (WECARE) Study which was specifically designed to examine the interaction of radiation exposure and genetic predisposition in breast cancer, especially radiation-associated contralateral breast cancer (CBC) among 3,700 women with CBC and unilateral breast cancer.

The WECARE Study has served as the source population for studies of candidate genes such as BRCA1, BRCA2, CHEK2, and ATM, candidate gene pathways of DNA damage response involved in radiation-induced double-strand break repair—ATM, CHEK2, P53 binding protein (53BPI), and MDC1, Mre11, Rad50, and Nbs1 (e.g., MRN nuclease complex), a genome-wide association study, and most recently mammographic density. The global hypothesis across these studies is that women who carry certain types of mutations will be more susceptible to breast cancer than noncarriers, and possibly to radiation-associated breast cancer. Dr. Bernstein currently serves as a member of the Board of Directors of the American College of Epidemiology, the External Advisory group for the NCI-sponsored Breast Cancer Family Registry, the National Council on Radiation Protection and Measurements, and most recently the NCI Board of Scientific Counselors-Clinical Sciences and Epidemiology.

For the past two years, she has served on the Organizing Committee of the American Statistical Association Conference on Radiation and Health (2012 and 2014 meetings), and was Co-Chair of the Third North American Congress of Epidemiology, held in June 2011 for which she was honored by the 2012 ACE Award for Leadership and Service in Epidemiology. Dr. Bernstein holds a PhD in Epidemiology from Yale University, an MS in Applied Biometry from the University of Southern California, and an AB from Brown University. Before joining the faculty at MSKCC, she was Deputy Director of the Division of Epidemiology at Mount Sinai School of Medicine.

Jonine L. Bernstein
SC 1-27 Evaluation of Sex-Specific Differences in Lung Cancer Radiation Risks and Recommendations for Use in Transfer and Projection Models WeilM

MICHAEL M. WEIL

WeilM

is a professor in the Department of Environmental and Radiological Health Sciences at Colorado State University (CSU). His research, which takes advantage of murine models of radiation carcinogenesis and leukemogenesis, is focused on understanding how radiation exposure can lead to cancer and why some individuals may be more susceptible than others. At CSU, Dr. Weil teaches a graduate level course in cancer genetics and lectures in courses on cancer biology, environmental carcinogenesis, principles of radiation biology, and the pathobiology of laboratory animals.

Dr. Weil earned his PhD in Microbiology from the University of Texas at Austin and was trained in cancer genetics and radiation biology in the Department of Biochemistry and Molecular Biology Biochemistry and the Department of Experimental Radiotherapy at the University of Texas M.D. Anderson Cancer Center. Dr. Weil is a former Radiation Research Society council member and has served on National Institutes of Health, U.S. Department of Defense, and National Aeronautics and Space Administration grant review panels.

michael m. weil

DAVID J. PAWEL

Pawel D

is currently a Special Government Employee (Expert) with the Radiation Protection Division of the U.S. Environmental Protection Agency (EPA) where he had served as Statistician since 1997. His current focus is the reassessment of the EPA radiogenic cancer risk estimates. He is a co-author of the Blue Book on EPA's most recent radiogenic risk models and an EPA technical report on its assessment of risks from radon in homes. In 2003, as the second Beebe Fellow, he studied methods to improve cancer-specific radiogenic risk estimates at the Radiation Effects Research Foundation (RERF) in Hiroshima, Japan and the National Cancer Institute in 2004. Dr. Pawel was a member of the RERF Statistics Department from 1992 to 1994. He is a member of NCRP and served on its committee on uncertainties in internal dose estimates. He is also a member of the U.S. delegation to the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), and he currently serves as Senior Technical Advisor for UNSCEAR's committee on Epidemiological Studies of Radiation and Cancer. He has a BS in Mathematics from the College of William and Mary, an MS in Statistics from Rutgers University, and a PhD in Statistics from the University of Wyoming.

david j. pawel
SC 1-28 Recommendations on Statistical Approaches to Account for Dose Uncertainties in Radiation Epidemiologic Risk Models Bernstein

Jonine L. Bernstein

Bernstein

is an Attending Epidemiologist at the Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City. Her core research focus is on breast cancer and gliomas and on understanding cancer risk and progression in order to identify those at highest risk because of gene carrier status, environmental exposures, or a combination of both. Dr. Bernstein is the Principle Investigator of the National Cancer Institute (NCI)-funded international 24-center Women's Environmental Cancer Radiation and Epidemiologic (WECARE) Study which was specifically designed to examine the interaction of radiation exposure and genetic predisposition in breast cancer, especially radiation-associated contralateral breast cancer (CBC) among 3,700 women with CBC and unilateral breast cancer.

The WECARE Study has served as the source population for studies of candidate genes such as BRCA1, BRCA2, CHEK2, and ATM, candidate gene pathways of DNA damage response involved in radiation-induced double-strand break repair—ATM, CHEK2, P53 binding protein (53BPI), and MDC1, Mre11, Rad50, and Nbs1 (e.g., MRN nuclease complex), a genome-wide association study, and most recently mammographic density. The global hypothesis across these studies is that women who carry certain types of mutations will be more susceptible to breast cancer than noncarriers, and possibly to radiation-associated breast cancer. Dr. Bernstein currently serves as a member of the Board of Directors of the American College of Epidemiology, the External Advisory group for the NCI-sponsored Breast Cancer Family Registry, the National Council on Radiation Protection and Measurements, and most recently the NCI Board of Scientific Counselors-Clinical Sciences and Epidemiology.

For the past two years, she has served on the Organizing Committee of the American Statistical Association Conference on Radiation and Health (2012 and 2014 meetings), and was Co-Chair of the Third North American Congress of Epidemiology, held in June 2011 for which she was honored by the 2012 ACE Award for Leadership and Service in Epidemiology. Dr. Bernstein holds a PhD in Epidemiology from Yale University, an MS in Applied Biometry from the University of Southern California, and an AB from Brown University. Before joining the faculty at MSKCC, she was Deputy Director of the Division of Epidemiology at Mount Sinai School of Medicine.

Jonine L. Bernstein
No Image

Harry M. Cullings

was Chief of the Statistics Department at the Radiation Effects Research Foundation (RERF) in Hiroshima and Nagasaki, Japan, until 2018 and is now a consultant to RERF, working on projects including new anthropomorphic dosimetry models of the human body and analysis of biodosimetry results. He has been conducting research at RERF since 1999. RERF is a public interest foundation funded by the Japanese Ministry of Health, Labour and Welfare and the U.S. Department of Energy (DOE). Dr. Cullings holds a BS in Fundamental Sciences from Lehigh University, and an MS in Medical Physics and PhD in Analytical Health Sciences (Biometrics) from the University of Colorado Health Sciences Center in Denver, Colorado. He completed a postdoctoral fellowship in Radiation Sciences, funded by the U.S. Department of Energy (DOE) at the University of Pittsburgh. The emphasis of Dr. Cullings’ research is on radiation dosimetry and other aspects of radiation epidemiology, including dosimetric uncertainty and applications of spatial statistics. Dr. Cullings has published numerous reports, papers in scientific journals, and book chapters on subjects related to radiation dosimetry and radiation health effects research. He served as a member of the Joint U.S.-Japan Working Group on the Reassessment of Atomic-Bomb Dosimetry, which created the Dosimetry System 2002 that is currently in use at RERF. Dr. Cullings served as a member of the executive council of the Radiation Research Society in 2019 to 2020. In 2020 he was appointed by the U.S. National Academy of Science to their Committee on the Assessment of Strategies for Managing Cancer Risks Associated with Radiation Exposure During Crewed Space Missions. Dr. Cullings was a member of the U.S. Environmental Protection Agency’s Radiation Advisory Committee from 2017 to 2021.

Harry M. Cullings
PAC 2

Willie O. Harris

has over 42 y of experience in radiation protection at power reactors, which has included over 25 y in program management and oversight. Prior to retirement he was the corporate radiation protection manager of the largest fleet of nuclear power plants in the United States. He is currently Senior Director of Radiation Protection for CN Associates. In this role, he has written several technical reports for the Electric Power Research Institute, provides consulting services for several sites in decommissioning and operational radiation protection programs at nuclear power plants.

He holds a bachelor’s degree in radiation protection. He is a certified health physicist, a registered radiation protection technologist, and held a senior reactor operator certification.

Mr. Harris has served on the Council since 2017 and is a member Program Area Committee 2 and the budget committee. He has been a member of the Health Physics Society since 1990. He is currently the Secretary for the AAHP Executive committee.

Willie O. Harris
SC 2-8 Operational Radiation Safety Program — Revision to Report No. 127 (1998) Pryor-K

KATHRYN H. PRYOR

Pryor-K

has been a member of Program Area Committee (PAC) 2 since 2007 and a member of NCRP since 2010. She has served on Scientific Committees 2-4, 2-5, 2-7, 1-19, and 6-9. Ms. Pryor is currently on the NCRP Board of Directors and is Scientific Vice President of PAC 2. She received her BS in Biology in 1979 and MS in Radiological Sciences in 1981, both from the University of Washington.

Ms. Pryor was the Chief Health Physicist at the Pacific Northwest National Laboratory (PNNL) in Richland, Washington, providing management and technical support to the PNNL Radiation Protection Division since 1992. She also served as the Chief Radiological Engineer for the design of the Pit Disassembly and Conversion Project. Ms. Pryor previously held radiation protection technical support positions at the San Onofre Nuclear Generating Station and the Trojan Nuclear Plant, and was the Radiation Safety Officer at the University of Southern California Health Sciences Campus.

Ms. Pryor is a Fellow member of the Health Physics Society (HPS) and served as President-Elect, President, and Past President from 2010 to 2013. She is certified in comprehensive practice by the American Board of Health Physics (ABHP), and served on the ABHP both as a member and Chair from 1998 to 2002. She is currently the President of the American Academy of Health Physics. Ms. Pryor was awarded the William McAdams Outstanding Service Award by ABHP in 2007 and the John P. Corley Meritorious Service Award by the Columbia Chapter of HPS in 2003.

kathryn h. pryor
PAC 3 Buddemeier B

BROOKE R. BUDDEMEIER

Buddemeier B

is an associate program leader in the Global Security Directorate of Lawrence Livermore National Laboratory (LLNL). He supports the Risk and Consequence Management Division in their efforts to evaluate the potential risk and consequence of radiological and nuclear terrorism. Mr. Buddemeier is a member of NCRP and served on the scientific committees which developed Commentary No. 19 - Key Elements of Preparing Emergency Responders for Nuclear and Radiological Terrorism (2005) and NCRP Report No. 165 – Responding to a Radiological or Nuclear Terrorism Incident: A Guide for Decision Makers (2010).

From 2003 through 2007, he was on assignment with the Department of Homeland Security's as the weapons of mass destruction emergency response and consequence management program manager for Science and Technology's emergency preparedness and response portfolio. He supported Federal Emergency Management Agency and the Homeland Security Operations Center as a radiological emergency response subject matter expert. He also facilitated the department's research, development, test and evaluation process to improve emergency response through better capabilities, protocols and standards. Prior to that, he was part of the LLNL Nuclear Counterterrorism Program and coordinated LLNL's involvement in the National Nuclear Security Administration's Radiological Assistance Program (RAP) for California, Nevada and Hawaii.

RAP is a national emergency response resource that assists federal, state and local authorities in the event of a radiological incident. As part of RAP's outreach efforts, Mr. Buddemeier has provided radiological responder training and instrumentation workshops to police, firefighters, and members of other agencies throughout the nation and abroad. He has also provided operational health physics support for various radiochemistry, plutonium handling, accelerator and dosimetry operations. He is Certified Health Physicist who received his Master's in Radiological Health Physics from San Jose State University and a BS in Nuclear Engineering from the University of California, Santa Barbara.

brooke r. buddemeier
SC 3-2 Recommendations for Instrument Response Verification and Calibration for Use in Radiation Emergencies
Leticia Pibida
KlemicG

Gladys A. Klemic

KlemicGis a physicist with the National Urban Security Technology Laboratory (NUSTL), a federal resource of the U.S. Department of Homeland Security which supports the development of technologies for emergency response agencies. She designs and conducts laboratory tests of radiation detectors, and operational field evaluations of prototype and commercially available equipment for firefighter and law enforcement agencies. She is active in national standards development and has been with NUSTL and its predecessor, the Environmental Measurements Laboratory since 1990. Her earlier work specialized in environmental thermoluminescence dosimetry, including conducting dosimeter research, measurements and analysis, and leading international intercomparisons. She has authored or co-authored 40 scientific and technical publications and is a member of the Health Physics Society and the National Fire Protection Association. She has a BS degree in Physics from Wayne State University and an MS degree in Physics from New York University.

Gladys A. Klemic
SC 3-3 Respiratory Protection for Emergency Workers Responding to a Nuclear/RadiologicalEmergency Ansari

ARMIN ANSARI

Ansari

is the Radiological Assessment Team Lead at the Centers for Disease Control and Prevention (CDC) serving as subject matter expert in CDC’s radiation emergency preparedness and response activities. He received his BS and PhD degrees in radiation biophysics from the University of Kansas, starting his career as a radiation biologist, and did his postdoctoral research in radiation-induced mutagenesis at Oak Ridge and Los Alamos National Laboratories. He was a senior scientist with the radiological consulting firm of Auxier & Associates before joining CDC in 2002. He has led the development of key national guidance documents including guides for population monitoring and operation of public shelters after radiation emergencies and a number of training products for public health professionals. He is a past president of the Health Physics Society, adjunct associate professor of nuclear and radiological engineering at Georgia Institute of Technology, member of Georgia East Metro Medical Reserve Corps and Gwinnett County Community Emergency Response Team, and provides consultancy to the International Atomic Energy Agency. Since 2014, he has served as member of the U.S. delegation to the United Nations Scientific Committee on the Effects of Atomic Radiation. He is the author of Radiation Threats and Your Safety: A Guide to Preparation and Response for Professionals and Community, a book specifically directed at audiences without radiation protection expertise.

armin ansari

ADELA SALAME-ALFIE

is a Senior Health Physicist in the Radiation Studies Section in the Centers for Disease Control and Prevention. Prior to this appointment, Dr. Salame-Alfie spent 22 y with the New York State Department of Health in various capacities including Director of the Division of Environmental Health Investigation, Director of Preparedness for the Center for Environmental Health, and Director of the Bureau of Environmental Radiation Protection.

Dr. Salame-Alfie is a member of NCRP, and co-chaired Scientific Committees (SC) 3-1 and 3-2 that prepared NCRP Report No. 179 and Commentary No. 28 addressing dosimetry guidance for radiation emergency workers; and SC 3-3 that prepared Statement No. 15 on respiratory protection guidance for workers and volunteers. She is a Lifetime member of the Conference of Radiation Control Program Directors where she served as Chair and member of the Board of Directors and chaired several committees and received the 2014 Gerald S. Parker Award. She is a Fellow member of the Health Physics Society and currently serves on the Board of Directors. She has extensive experience in many areas of radiation protection including radiological emergency preparedness and response, environmental radiation and radon and has published and co-authored many publications.

Dr. Salame-Alfie obtained her MS and PhD in Nuclear Engineering from Rensselaer Polytechnic Institute in Troy, New York.

Adela Salame-Alfie
PAC 4 Miller D

DONALD L. MILLER

Miller Dis the Chief Medical Officer for the Office of Radiological Health at the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health. He earned a BA from Yale University and an MD from New York University, and completed a residency in diagnostic radiology and a fellowship in interventional radiology at New York University Medical Center. He is board certified in Diagnostic Radiology and Vascular and Interventional Radiology. Prior to joining FDA, he practiced interventional radiology for three decades at the National Institutes of Health and the National Naval Medical Center in Bethesda, Maryland.

Dr. Miller was elected to NCRP in 2006. He currently serves on the Board of Directors and as Chair of Program Area Committee 4 (Radiation Protection in Medicine). He is an author of NCRP Reports Nos. 168, 172, 177, 180, 184, and 185, and Statements Nos. 11 and 13. He served on the International Commission on Radiological Protection (ICRP) Committee 3 (Protection in Medicine) as a member from 2010 to 2013, and as Vice-Chair from 2013 to 2017. He is an author of ICRP Publications 117, 120, 135, and 139. He was Vice-Chair for the U.S. Environmental Protection Administration’s Federal Guidance Report No. 14, is a consultant to the International Atomic Energy Agency, and is a member of the World Health Organization’s Core Group of Experts on radiation protection of patients and staff.

Dr. Miller was Professor of Radiology at the Uniformed Services University in Bethesda, Maryland from 1993 to 2012. He has served as Associate Editor of Radiology and the Journal of Vascular and Interventional Radiology and is an author of more than 200 papers in peer-reviewed journals and more than 40 book chapters and reports. He is a Fellow of the Society of Interventional Radiology (SIR) and the American College of Radiology (ACR), and an Honorary Member of both the American Association of Physicists in Medicine and the International Organization for Medical Physics. He chaired SIR’s Safety and Health Committee from 1999 to 2011 and the ACR Guidelines Interventional Committee from 2008 to 2012. His research interests have centered on radiation protection in medicine.

donald l. miller

Dr. Lawrence Dauer

LAWRENCE T. DAUER

is an Attending Physicist in the Departments of Medical Physics and Radiology at Memorial Sloan Kettering Cancer Center and serves at their Corporate Radiation Safety Officer. He serves as a member of the Nuclear and Radiation Studies Board of the National Academy of Sciences, Engineering and Medicine. He is a former Board member and current Council member of NCRP and is the Scientific Director of the Million Person Study. He has served as Chair or Co-Chair on several NCRP scientific committees associated with radiation protection of workers, patients, and members of the public. He served 7 y on the International Commission on Radiological Protection Committee 3, Radiation Protection in Medicine.

lawrence t. dauer
SC 4-10 Error Prevention in Radiation Therapy

STEVEN G. SUTLIEF

Sutlief_S

is currently a medical physicist with the Banner MD Anderson Cancer Center in Phoenix, Arizona and an adjunct professor at San Diego State University. He received his PhD in experimental particle physics from the University of Washington and subsequently completed a post-doctoral fellowship in radiation therapy medical physics at the University of Washington with research in intensity modulated radiation therapy. He has been chief medical physicist at the Veterans Affairs (VA) Puget Sound Health Care System in Seattle and an affiliate faculty member in the University of Washington School of Medicine, a professor at the University of California San Diego and a medical physicist with Landauer Medical Physics. Dr. Sutlief worked to advance radiation therapy within the VA, including agency-wide radiotherapy equipment modernization, radiotherapy device interconnectivity, consultation for the VA National Health Physics Program, participation in several investigations, and development of qualification standards for therapeutic medical physicists. He has coauthored more than 50 articles and book chapters related to therapeutic medical physics. Dr. Sutlief developed and taught the physics curriculum for the Bellevue College Medical Dosimetry program. He has served as a consultant to the International Atomic Energy Agency and as a member of the Radiation Oncology planning group for the Integrating the Healthcare Enterprise. Dr. Sutlief was a Co-organizer for the AAPM Summer School on Quality and Safety in Radiation Therapy and was a faculty member for the Veterans Health Administration Biennial Conference on Radiation Oncology. He actively participates in the American Association of Physicists in Medicine, where he has served on many committees and on several task group reports. He is currently an NCRP Council member.

steven g. sutlief

Michael T. Milano

is a board certified radiation oncologist who practices at the University of Rochester Medical Center. He attended the University of Rochester for medical school and graduate school, and holds a PhD in biophysics. His residency training was at the University of Chicago. He is currently a Professor, Director of the Residency Program in Radiation Oncology and Director of the Stereotactic Radiotherapy Program. He has clinical expertise in the radiotherapy of thoracic malignancies as well as benign and malignant tumors of the central nervous system. Dr. Milano’s clinical research has been devoted to investigating the clinical outcomes of patients treated with newer technologies, as well as the treatment of patients with oligometastatic disease. Additional research interests include cancer survivorship, with a focus on second malignancies and late effects of cancer therapy. He has served on committees for the American Society of Radiation Oncology and American Association of Physicists in Medicine.

Michael T. Milano
SC 4-11 Gonadal Shielding During Abdominal and Pelvic Radiography

Donald P. Frush

Frush-D

is the John Strohbehn Professor of Radiology, and an Associate Faculty Member, Medical Physics Graduate Program at Duke University Medical Center. Dr. Frush earned his undergraduate degree from the University of California Davis, MD from Duke University School of Medicine, was a pediatric resident at University of California San Francisco, completed a radiology residency at Duke Medical Center, and a fellowship in pediatric radiology at Children’s Hospital in Cincinnati. Professional roles included more than 25 y on the Duke Medical Center faculty, with a subsequent nearly 2 y appointment as a Professor of Radiology at Lucile Packard Children’s Hospital at Stanford. He returned to Duke in 2020. Dr. Frush’s research interests are predominantly involved with pediatric body computed tomography (CT), including technology assessment, techniques for pediatric CT examinations, assessment of image quality, radiation dosimetry, and radiation protection and risk communication in medical imaging. Other areas of investigation include CT applications in children and patient safety in radiology.

Donald P. Frush

Keith J. Strauss

is an Associate Professor at the University of Cincinnati School of Medicine and the head of the Section of Clinical Medical Physics within the Radiology Department of Cincinnati Children’s Hospital Medical Center. Mr. Strauss received a BA degree in physics from the University of Manchester and an MSc degree in radiologic physics from the University of Chicago. He began his career as a Diagnostic Medical Physicist at Michael Reese Hospital in Chicago before focusing on pediatric Radiology in Boston and Cincinnati since 1984.

Mr. Strauss’ research interests are predominantly focused on altered clinical configurations of x-ray imaging equipment designed to manage the pediatric patient’s radiation dose while maintaining good quality imaging. International affiliations include the International Atomic Energy Agency and pediatric hospitals associated with Project HOPE. Mr. Strauss is active on committees within the American Association of Physicists (AAPM) in Medicine and American College of Radiology (ACR). He is currently the Vice Chair of the Image Gently Alliance, a Fellow of the ACR, and a Fellow of the AAPM.

Keith J. Strauss
SC 4-12 Risk Management Stratification of Equipment and Training for Fluoroscopy
Balter

Stephen Balter

is a Clinical Professor of Radiology and Medicine at Columbia University. He earned an MS in Radiological Physics and a PhD in Experimental Physics. He is certified in Radiological Physics by the American Board of Radiology and licensed by New York State in Diagnostic Imaging, Radiation Therapy Physics, and Medical Health Physics. He is a past President of the Radiological and Medical Physics Society of New York, past Vice President of the Radiological Society of North America, a member of the Standards and Safety Committees of the Society for Interventional Radiology, and a member of editorial and review boards of several scientific journals. He received the Marvin M.D. Williams award from the American Association of Physicists in Medicine (AAPM) in 2017. He is a fellow of AAPM, the American College of Medical Physics, the American College of Radiology, the Society for Cardiovascular Angiography and Interventions, and the Society of Interventional Radiology. He currently serves on International Electrotechnical Commission working groups responsible for safety and performance standards for projection and interventional radiology. He has been a member of NCRP Council for more than a decade. He chaired scientific committees that produced NCRP Report No. 168, Radiation Dose Management for Fluoroscopically-Guided Interventional Medical Procedures and NCRP Statement No. 11, Outline of Administrative Policies for Quality Assurance and Peer Review of Tissue Reactions Associated with Fluoroscopically-Guided Interventions (2014). He has over 100 refereed publications in the areas of radiological imaging, radiological health, and related topics.

Stephen Balter

DONALD L. MILLER

Miller Dis the Chief Medical Officer for the Office of Radiological Health at the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health. He earned a BA from Yale University and an MD from New York University, and completed a residency in diagnostic radiology and a fellowship in interventional radiology at New York University Medical Center. He is board certified in Diagnostic Radiology and Vascular and Interventional Radiology. Prior to joining FDA, he practiced interventional radiology for three decades at the National Institutes of Health and the National Naval Medical Center in Bethesda, Maryland.

Dr. Miller was elected to NCRP in 2006. He currently serves on the Board of Directors and as Chair of Program Area Committee 4 (Radiation Protection in Medicine). He is an author of NCRP Reports Nos. 168, 172, 177, 180, 184, and 185, and Statements Nos. 11 and 13. He served on the International Commission on Radiological Protection (ICRP) Committee 3 (Protection in Medicine) as a member from 2010 to 2013, and as Vice-Chair from 2013 to 2017. He is an author of ICRP Publications 117, 120, 135, and 139. He was Vice-Chair for the U.S. Environmental Protection Administration’s Federal Guidance Report No. 14, is a consultant to the International Atomic Energy Agency, and is a member of the World Health Organization’s Core Group of Experts on radiation protection of patients and staff.

Dr. Miller was Professor of Radiology at the Uniformed Services University in Bethesda, Maryland from 1993 to 2012. He has served as Associate Editor of Radiology and the Journal of Vascular and Interventional Radiology and is an author of more than 200 papers in peer-reviewed journals and more than 40 book chapters and reports. He is a Fellow of the Society of Interventional Radiology (SIR) and the American College of Radiology (ACR), and an Honorary Member of both the American Association of Physicists in Medicine and the International Organization for Medical Physics. He chaired SIR’s Safety and Health Committee from 1999 to 2011 and the ACR Guidelines Interventional Committee from 2008 to 2012. His research interests have centered on radiation protection in medicine.

donald l. miller
PAC 5 Kennedy-W

WILLIAM E. KENNEDY, JR.

Kennedy-W

has extensive experience as a project manager, task leader, and individual contributor covering a broad range of health physics and nuclear engineering topics. He received his BS and MS degrees in Nuclear Engineering from Kansas State University. Mr. Kennedy has been involved in the development of environmental pathway and radiation dosimetry models used to assess potential health and environmental impacts that resulted from releases of radionuclides to the environment.

He specializes in the use of these models in environmental dose reconstruction, radioactive materials transport, radioactive waste disposal, and evaluation of nuclear facility operating practices. Over the past 37 y, Mr. Kennedy has led and contributed to a variety of projects for the U.S. Nuclear Regulatory Commission, the U.S. Department of Energy, the Electric Power Research Institute, and private industry. He has been involved with development of the technical basis for revised standards and regulations, and serves as the chair of ANSI/HPS N13.12, Surface and volume Radioactivity Standards for Clearance. He served as a consultant to the International Atomic Energy Agency (IAEA), Vienna, Austria, and was a member of the IAEA Advisory Groups to evaluate the Derivation of Exempt Quantities for Application to Terrestrial Waste Disposal and Derivation of Exempt Quantities for Recycle of Materials from Nuclear Facilities.

He was an invited lecturer for IAEA training courses on Management of Radioactive Waste from Nuclear Power Plants at Argonne National Laboratory; on Safety Assessment Modeling for Low and Intermediate Radwastes in Rio de Janeiro, Brazil and in Cairo, Egypt; and on Environmental Monitoring in Kiev, Ukraine. In 1990, he received the Health Physics Society's (HPS) prestigious Elda E. Anderson Award. He served as a member of the HPS Board of Directors from 1998 through 2001 and was selected as a fellow of the society in 2002. He was a member of the U.S. delegation to the 10th Congress of the International Radiation Protection Association in Hiroshima, Japan.

william e. kennedy, jr.
PAC 6 Simon S

STEVEN L. SIMON

Simon S

received a BS in Physics from the University of Texas, an MS in Radiological Physics from the University of Texas Health Sciences Center in Dallas, and a PhD in Radiological Health Sciences from Colorado State University. Early in his career, he worked in medical physics and was the first treatment planner for clinical trials of treatments of solid tumors with negative pi-mesons at the Los Alamos Physics Meson Facility. Later specializing in environmental radioactivity and assessment, he directed the first and only nationwide monitoring program of the Marshall Islands for residual contamination from nuclear testing. He also participated in the radiological monitoring of numerous other nuclear test sites worldwide including Johnston Island, French Polynesia, and Algeria and has lead, or participated in, radiation health risk studies of fallout exposures in Utah, the Marshall Islands, and Kazakhstan.

In 2000, Dr. Simon joined the National Cancer Institute's (NCI) Radiation Epidemiology Branch as an expert in dose reconstruction and led the Dosimetry Unit in that Branch for more than 6 y. His research program included methods for reconstructing historical doses, particularly to medical workers, atomic veterans, persons exposed to radioactive fallout in the Marshall Islands and in the United States – particularly in Utah and in New Mexico, and in the development of methods for characterizing uncertainties of estimated doses and using those uncertainties in radiation risk analyses. He led the first and only assessment of exposures from the world’s first nuclear test, TRINITY, as well as the development of a complete suite of methods for assessing doses from nuclear fallout. He retired from the NCI in 2022.

Dr. Simon has been a member of NCRP since 2006 and the Chair of Program Area 6 – Radiation Measurements and Dosimetry since 2013. He was an Associate Editor of Health Physics for 25 y and, in 2021, was awarded the Distinguished Scientific Achievement Award by the Health Physics Society. In 2011 during the Fukushima nuclear crisis, he was deployed by the U.S. Department of Health and Human Services to the U.S. Embassy in Japan to assist with the protection of American citizens. He was on assignment in 2016 to the International Agency for Research on Cancer (Lyon, France) to develop methods for assessing doses and uncertainties to a study cohort of one million children exposed to radiation from computed tomography exams. In recent years, he has been a consultant to the United Nations Scientific Committee on the Effects of Atomic Radiation for occupational exposures.

steven l. simon
SC 6-13 Methods and Models for Estimating Organ Doses from Intakes of Radium Derek Jokisch
No ImageNicole Martinez
PAC 7 Radiation Education, Risk Communication, and Outreach HyerR

Randall N. Hyer

has over three decades’ experience in high-concern, low-trust public communications. He advises the National Academy of Sciences, Engineering and Medicine, lectures at Harvard University, and advises/educates both individuals and organizations on how to implement best practices in risk and crisis communication.

His diverse experience covers disease outbreaks, nuclear emergencies, natural disasters, outbreak investigations, product safety concerns, reorganizations and downsizing, budget cuts, rogue employee mitigations, health hazard evaluations, and strategic communications. As the Senior Vice President for Global Medical at Moderna, Dr. Hyer helped develop, communicate, and manage the global rollout of the Moderna COVID-19 mRNA vaccine. In 2017, he was pivotal in engaging the scientific, medical and policy communities to achieve Food and Drug Administration approval of a new adult hepatitis B vaccine (HEPLISAV-B®), the first vaccine using a truly novel adjuvant.

Board-certified in general preventive medicine and public health, Dr. Hyer earned his MD from Duke and trained at Walter Reed Hospital and Harvard. He received the PhD from the University of Oxford researching the genetics of juvenile diabetes. His studies won the National Institutes of Health "Outstanding Research Award for Clinical Trainees" and are widely cited.

At Oxford University, Dr. Hyer founded the biotechnology company, Alpha-Plus DNA. He also served as a U.S. Congressional Fellow for Senator Pete V. Domenici (R. -NM). Dr. Hyer helped introduce legislation to safeguard genetic privacy that eventually became the Genetic Information Non-discrimination Act (GINA) of 2008.

Dr. Hyer graduated with Distinction from the U.S. Naval Academy. Rising to the rank of Commander, his naval service included four major military combat operations in Europe and southwest Asia as well as three major complex humanitarian emergencies with Kosovo relief, Mozambique flood relief, and the Indian Ocean tsunami. Dr. Hyer also served as the Winter-Over Medical Officer at the McMurdo and South Pole Stations, Antarctica as the sole physician.

At the World Health Organization (WHO) in Geneva, Dr. Hyer served as a Medical Officer and Military Liaison. Among other duties, he helped facilitated the WHO response to various crisis such as anthrax, Ebola, the 2003 SARS outbreak, tsunamis, earthquakes, and pandemic influenza.

Dr. Hyer’s perspectives and contributions span his residing in eight and travelling to 100 plus countries in diverse roles across the public and private sectors.

Randall N. Hyer
PAC 8 SavitzD

David A. Savitz

SavitzDis Professor of Epidemiology in the Brown University School of Public Health, with a joint appointment in Obstetrics and Gynecology in the Alpert Medical School. His epidemiological research has addressed a wide range of many important public health issues including environmental hazards in the workplace and community, reproductive health outcomes, and environmental influences on cancer. He has done extensive work on health effects of nonionizing radiation, pesticides, drinking water treatment byproducts, and perfluorinated compounds.

He has directed 30 doctoral dissertations and 15 master’s theses. He is the author of over 400 papers in professional journals and editor or author of three books. He has served as editor at the American Journal of Epidemiology and as a member of the Epidemiology and Disease Control-1 study section of the National Institutes of Health and currently is an editor at Epidemiology. He was President of the Society for Epidemiologic Research and the Society for Pediatric and Perinatal Epidemiologic Research and North American Regional Councilor for the International Epidemiological Association. Dr. Savitz is a member of the National Academy of Sciences Institute of Medicine.

He came to Brown in 2010 from Mount Sinai School of Medicine, where he had served as the Charles W. Bluhdorn Professor of Community and Preventive Medicine and Director of Disease Prevention and Public Health Institute since 2006. Earlier, he taught and conducted research at the University of North Carolina School of Public Health and at the Department of Preventive Medicine and Biometrics at the University of Colorado School of Medicine. Dr. Savitz received his undergraduate training in Psychology at Brandeis University, a Master’s degree in Preventive Medicine at Ohio State University in 1978, and the PhD in Epidemiology from the University of Pittsburgh Graduate School of Public Health in 1982.

David A. Savitz
SC 8-1 Development of NCRP Informational Webpages to Provide Authoritative Information About the Use of Wireless Technology and Current Evidence on Health Effects SavitzD

David A. Savitz

SavitzDis Professor of Epidemiology in the Brown University School of Public Health, with a joint appointment in Obstetrics and Gynecology in the Alpert Medical School. His epidemiological research has addressed a wide range of many important public health issues including environmental hazards in the workplace and community, reproductive health outcomes, and environmental influences on cancer. He has done extensive work on health effects of nonionizing radiation, pesticides, drinking water treatment byproducts, and perfluorinated compounds.

He has directed 30 doctoral dissertations and 15 master’s theses. He is the author of over 400 papers in professional journals and editor or author of three books. He has served as editor at the American Journal of Epidemiology and as a member of the Epidemiology and Disease Control-1 study section of the National Institutes of Health and currently is an editor at Epidemiology. He was President of the Society for Epidemiologic Research and the Society for Pediatric and Perinatal Epidemiologic Research and North American Regional Councilor for the International Epidemiological Association. Dr. Savitz is a member of the National Academy of Sciences Institute of Medicine.

He came to Brown in 2010 from Mount Sinai School of Medicine, where he had served as the Charles W. Bluhdorn Professor of Community and Preventive Medicine and Director of Disease Prevention and Public Health Institute since 2006. Earlier, he taught and conducted research at the University of North Carolina School of Public Health and at the Department of Preventive Medicine and Biometrics at the University of Colorado School of Medicine. Dr. Savitz received his undergraduate training in Psychology at Brandeis University, a Master’s degree in Preventive Medicine at Ohio State University in 1978, and the PhD in Epidemiology from the University of Pittsburgh Graduate School of Public Health in 1982.

David A. Savitz
Back to Top
Last modified: May 25, 2015